Article

B and T cell responses after a third dose of SARS-CoV-2 vaccine in Kidney Transplant Recipients

2021-08-12

Abstract excerpt

<h4>Background</h4> Accumulating evidence suggests that solid organ transplant recipients, as opposed to the general population, show strongly impaired responsiveness towards standard SARS-CoV-2 mRNA-based vaccination, demanding alternative strategies for protection of this vulnerable group. <h4>Methods</h4> In line with recent recommendations, a third dose of either heterologous ChAdOx1 (AstraZeneca) or homologou...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 02d704a2-a663-51ad-9ab2-af13c9748038
DOI: 10.1101/2021.08.12.21261966

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

B and T cell responses after a third dose of SARS-CoV-2 vaccine in Kidney Transplant RecipientsDOI 10.1101/2021.08.12.21261966Read

Comparative immunogenicity of heterologous versus homologous 3rd SARS-CoV-2 vaccine doses in kidney transplant recipientsSemantic proximity Read

Humoral immune responses against SARS-CoV-2 variants including omicron in solid organ transplant recipients after three doses of a COVID-19 mRNA vaccineSemantic proximity Read

Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipientsSemantic proximity Read

Vaccine serologic responses among transplant patients associate with COVID-19 infection and T peripheral helper cellsSemantic proximity Read

Safety and Cross-Variant Immunogenicity of a Three-Dose COVID-19 mRNA Vaccine Regimen in Kidney Transplant RecipientsSemantic proximity Read

Cellular and humoral responses to SARS-CoV-2 vaccination in immunosuppressed patientsSemantic proximity Read

Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipientsSemantic proximity Read

A Third Dose of SARS-CoV-2 Vaccine Increases Neutralizing Antibodies Against Variants of Concern in Solid Organ Transplant RecipientsSemantic proximity Read

HUMORAL AND CELLULAR IMMUNOGENICITY and SAFETY UP TO 4 MONTHS AFTER VACCINATION WITH BNT162B2 mRNA COVID-19 VACCINE IN HEART AND LUNG TRANSPLANTED YOUNG ADULTSSemantic proximity Read

A Third COVID-19 Vaccine Dose in Kidney Transplant Recipients Induces Antibody Response to Vaccine and Omicron Variants but Shows Limited Ig Subclass SwitchingSemantic proximity Read

Cellular and Humoral Responses to SARS-CoV-2 Vaccination in Immunosuppressed PatientsSemantic proximity Read

SARS-CoV-2 T-Cell Responses in Allogeneic Hematopoietic Stem Cell Recipients following Two Doses of BNT162b2 mRNA VaccineSemantic proximity Read